DEA moves to temporarily schedule 7-OH and related substances over safety concerns
The US Drug Enforcement Administration (DEA) announced on July 1, 2026, plans to temporarily place 7-hydroxymitragynine (7-OH) and related substances under federal scheduling controls. The action is intended to protect public safety while the agency conducts further review of these compounds. Temporary scheduling gives the DEA authority to restrict the manufacture, distribution, and possession of the targeted substances. 7-OH is a potent active compound derived from kratom, a plant that has faced growing regulatory scrutiny in recent years.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in